Abstract

Background:

This study aimed to compare the effects of different gamete co-incubation times on fertilization, embryo development potential, along with clinical outcomes.

Methods:

The study included 530 cycles with short co-incubation times (4–6 hours), referred to as the S group, and 1653 cycles with long co-incubation times (16–24 hours), referred to as the L group, all undergoing in vitro fertilization (IVF) without rescue intracytoplasmic sperm injection (R-ICSI). The study analyzed the basic characteristics and clinical outcomes of these two groups. Additionally, the study stratified the cycles based on the number of oocytes retrieved and performed multivariate logistic regression analysis with the normal fertilization (two pronuclei, 2PN) rate as the dependent variable and co-incubation time as the main independent variable. The study also examined 79 partial short co-incubation cycles, dividing them into a short co-incubation part (10 oocytes) and a long co-incubation part (the remaining oocytes), to analyze embryo developmental parameters.

Results:

There were no significant differences in the rates of top-quality blastocyst formation, clinical pregnancy, and implantation between the two groups (p > 0.05). 2PN rate in S group was slightly lower than in L group (68.06% vs. 71.08%, p < 0.01). After stratifying by the number of oocytes obtained, multiple logistic regression analysis demonstrated no significant correlation between co-incubation time and 2PN rate (p > 0.05). In the 79 partial short co incubation cycles, there were no significant differences in the rates of 2PN oocytes, ≥3PN (3 pronuclei) oocytes, top-quality cleavage embryos, and top-quality blastocysts on Day 5/Day 6 between the two parts (p > 0.05).

Conclusions:

Short oocyte-sperm co-incubation is an effective strategy in preventing fertilization failure. Short and long oocyte-sperm co-incubation times have similar outcomes on in vitro development.

1. Introduction

In vitro fertilization (IVF) is widely used to treat infertile couples. Compared with intracytoplasmic sperm injection (ICSI), the combination of oocytes and sperm in IVF more closely mimics the natural human physiological state [1, 2]. However, even with normal semen parameters, approximately 20% of IVF cycles result in a low fertilization rate (<25%), and 5% to 15% of cycles experience complete fertilization failure [3, 4]. Such failures place considerable pressure on both doctors and patients. To avoid fertilization failure, some centers perform ICSI on all or part of the oocytes, which leads to the over-application of ICSI [5]. Compared with conventional IVF, the use of ICSI does not improve the transplantation or live birth rates in non-male factor infertility couples [1]. Given the risks of oocyte damage and the potential transmission of genetic defects in male infertility to the next generation, IVF remains the first option for treating non-severe male infertility. A viable option for addressing fertilization failure after IVF is early rescue ICSI [6]. It was provided to those oocytes with unclear release of the second polar body 6 h after initial insemination. The short co-incubation of gametes combined with early rescue ICSI can alleviate the stress of fertilization failure and effectively limit the overuse of ICSI [7]. However, whether short co-incubation of gametes should be used in all IVF cycles remains unclear.

There is still no consensus on the optimal duration for oocyte-sperm co-incubation during IVF. Some studies suggest that short co-incubation times (1–6 hours) improve IVF outcomes compared to longer co-incubation times (16–24 hours) [8, 9]. Conversely, other studies have found no such advantage [10, 11]. A previous study indicated that prolonged exposure of oocytes to sperm might harm early embryonic development [12]. Barraud-Lange et al. [13] found that while short co-incubation of gametes reduced the fertilization rate compared to the standard overnight method, embryo quality remained comparable. Fan et al. [9] meta-analysis revealed that reduced gamete co-incubation time benefits clinical pregnancy and implantation rates compared to overnight IVF, with no significant differences in fertilization rates or embryo quality. Our study aimed to investigate these findings further and provide a reference for clinical practice.

2. Materials and Methods
2.1 Patients

We retrospectively analyzed the data of patients receiving IVF/ICSI assisted pregnancy at the Reproductive Center of Changzhou Maternal and Child Health Care Hospital from January 2022 to December 2023. The inclusion criteria: oocyte retrieval cycles. The exclusion criteria: (1) cycles with frozen-thawed oocytes or sperm; (2) patients with chromosomal abnormalities; (3) ICSI cycles; (4) IVF/ICSI split insemination cycles; (5) rescue ICSI cycle. This study included 530 short co-incubation cycles without rescue ICSI as S group, and 1653 long co-incubation cycles without rescue ICSI as L group (Fig. 1). All patients read and signed informed consent forms. The Ethics Committee of Changzhou Maternal and Child Health Care Hospital approved this retrospective study (2022071). All treatments followed the Declaration of Helsinki for Medical Research. We performed multivariate logistic regression analysis to identify gamete co-incubation times associated with the 2PN rate. Furthermore, we analyzed data from 79 partial short co-incubation cycles, comparing fertilization and embryo development between short and long co-incubation cycles.

Fig. 1.

Flow of data acquisition and analysis. IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection.

2.2 Ovarian Stimulation

Oocytes were retrieved from females undergoing controlled ovarian stimulation using gonadotropin-releasing hormone (GnRH) analogs or other agents, or during a natural cycle. During ovarian stimulation, the daily dose of recombinant follicle stimulating hormone or human menopausal gonadotropin (FSH/HMG) was adjusted according to the size of the follicles observed on ultrasound. When at least three dominant follicles reached a diameter of 18 mm, 5000 IU of human chorionic gonadotropin (HCG) was administered to trigger oocyte maturation. Oocytes were extracted approximately 36 hours after triggering.

2.3 IVF Procedures

IVF insemination was adopted when sperm concentration was >5 × 106/mL, progressively motile sperm >10%, and total progressively motile sperm count >1.5 × 106 after semen optimization. Between 5000–10,000 progressively motile sperm were added to 30 µL insemination droplets. Insemination was completed within 38 to 40 hours after the trigger. In the S group, cumulus cells were removed mechanically 4 hours after insemination, and the oocytes were transferred to a balanced fresh medium for polar body observation. When less than 30% of the oocytes showed the release of the second polar body, they were rechecked 6 hours after insemination [14]. Normal fertilization was defined as the proportion of oocytes with the release of the second polar body being more than 50% [15]. In the traditional IVF group, cumulus cells were extracted after co-incubation for 18–20 hours. Pronucleus observations, embryo culture methods, and embryo scoring were performed as previously described [16]. Furthermore, we analyzed the clinical outcome of the first fresh embryo transfer. Clinical pregnancy was confirmed by the presence of a gestational sac with fetal heartbeat (14 days after biochemical pregnancy). Clinical pregnancy rate = No. of clinical pregnancy/fresh embryo transfer (ET) cycles × 100%.

2.4 Statistical Analysis

All analyses were performed using IBM SPSS Statistics 21 (IBM Corp., Chicago, IL, USA). The Chi-square test was used to compare categorical data. Normality was tested for continuous data. The Student’s t-test was used to compare normally distributed data. Non-normally distributed data were compared using the Mann-Whitney U test. Multivariate logistic regression was used to analyze the relationship between the 2PN rate and co-incubation time. Combined odds ratios (OR) and 95% confidence intervals (95% CI) were calculated for the data. A p-value of <0.05 was considered statistically significant.

3. Results
3.1 Baseline Characteristics of Cycles and Patients

530 short co-incubation cycles with normal fertilization in the S group and 1653 long co-incubation cycles with normal fertilization in the L group were included. There were no significant differences between the 2 groups in terms of female body mass index (BMI), basal estrogen (E2) levels, fallopian tube factors, or endometriosis factors (p > 0.05). However, the percentage of primary infertility, duration of infertility in years, ovulation disorders, male factors, basal luteinizing hormone (LH) levels, anti-Müllerian hormone (AMH) levels, GnRH agonist stimulation cycles, GnRH antagonist stimulation cycles, and total gonadotropin (Gn) use were significantly higher in the S group compared to the L group (p < 0.05). Conversely, the age of both males and females, the primary diagnosis of decreased ovarian reserve, unexplained factors, basal FSH levels, and the percentage of mild stimulation cycles were significantly lower in the S group than in the L group (p < 0.05, Table 1).

Table 1. Demographic characteristics of patients.
S Group L Group p-value
No. of patients (n) 530 1653
Primary infertility (%) 379/530 (71.51%) 626/1653 (37.87%) <0.01a
Infertility duration (years) 3 [2, 5] 2 [1, 4] <0.01b
Age (years)
Female 32 [29, 35] 33 [31, 36] <0.01b
Male 31 [28, 34] 33 [30, 36] <0.01b
BMI of female (kg/m2) 22.8 [20.4, 25.8] 22.8 [20.7, 25.6] 0.82b
Primary diagnosis
Tubal factor (%) 220/530 (41.51%) 736/1653 (44.53%) 0.22a
Endometriosis (%) 26/530 (4.91%) 54/1653 (3.27%) 0.08a
DOR (%) 34/530 (6.42%) 349/1653 (21.11%) <0.01a
Male factors (%) 38/530 (7.17%) 53/1653 (3.21%) <0.01a
Ovulation disorders (%) 77/530 (14.53%) 109/1653 (6.59%) <0.01a
Unexplainable factor (%) 106/530 (20.00%) 182/1653 (11.01%) <0.01a
Female hormone levels
Basal FSH (IU/L) 6.04 [5.11, 7.21] 6.55 [5.43, 8.11] <0.01b
Basal E2 (ng/L) 38.16 [29.38, 48.26] 38.71 [28.97, 50.88] 0.48b
Basal LH (IU/L) 5.33 [3.93, 7.31] 4.54 [3.27, 6.19] <0.01b
AMH (mg/dL) 3.22 [2.05, 4.88] 1.83 [0.86, 3.65] <0.01b
Simulation protocol
GnRH agonist (%) 335/530 (63.21%) 670/1653 (40.53%) <0.01a
GnRH antagonist (%) 172/530 (32.45%) 385/1653 (23.29%) <0.01a
Mild stimulation (%) 23/530 (4.34%) 598/1653 (36.18%) <0.01a
Total dose of Gn 1650.00 [1237.50, 2362.50] 1500.00 [1050.00, 2218.75] <0.01b

AMH, anti-Müllerian hormone; DOR, declined ovarian reserve; Gn, gonadotropin; GnRH, gonadotropin-releasing hormone; BMI, body mass index; FSH, follicle stimulating hormone; E2, basal estrogen; LH, luteinizing hormone. Data are presented as the median [the first quartile, the third quartile] or count (percentage). a, Chi-squared test; b, Mann–Whitney U test.

3.2 Comparison of Embryo Developmental and Clinical Outcome between S and L Groups

The rate of 3PN oocytes and top blastocyst formation were comparable between the S and L groups. The normal fertilization rate was slightly lower in the S group than in the L group, with statistical significance (p < 0.05). The average total oocyte retrieval and metaphase Ⅱ (MⅡ) oocytes, as well as top cleavage embryos from 2PN, were higher in the S group than in the L group, with statistical significance. In the S group, a total of 155 cleavage embryos and 54 blastocyst fresh ET cycles were included, while 267 cleavage embryos and 89 blastocyst fresh ET cycles were included in the L group. Cleavage embryos and blastocysts per transfer were comparable between the 2 groups. There was no significant difference in the rates of clinical pregnancy and implantation between the 2 groups (Table 2).

Table 2. Outcomes of embryo development and clinical outcomes in 2 groups.
S Group (n = 530) L Group (n = 1653) p-value
Average oocytes retrieved (n) 11 [8, 14] 7 [3, 12] <0.01b
Average MII oocytes (n) 10 [7, 13] 6 [3, 11] <0.01b
2PN oocytes rate (%) 4057/5961 (68.06%) 10,048/14,136 (71.08%) <0.01a
3PN oocytes rate (%) 519/5961 (8.71%) 1125/14,136 (7.96%) 0.08a
Top cleavage embryos from 2PN (%) 3339/4726 (70.65%) 7658/11,495 (66.62%) <0.01a
Top blastocyst formation rate (%) 1722/3225 (53.40%) 3809/7331 (51.96%) 0.17a
Fresh ET cycles 0.82a
Cleavage embryo 155 (74.16%) 267 (75.00%)
Blastocyst 54 (25.84%) 89 (25.00%)
No. of embryos transferred 0.70a
Cleavage embryo 274 (82.78%) 460 (83.79%)
Blastocyst 57 (17.22%) 89 (16.21%)
Clinical pregnancy rate (first ET)
Cleavage embryo 87/155 (56.13%) 154/267 (57.68%) 0.76a
Blastocyst 28/54 (51.85%) 49/89 (55.06%) 0.70a
Implantation rate (%)
Cleavage embryo 111/274 (40.51%) 196/460 (42.61%) 0.57a
Blastocyst 29/57 (50.88%) 49/89 (55.06%) 0.62a

Data are presented as the median [the first quartile, the third quartile] or count (percentage). a, Chi-squared test; b, Mann–Whitney U test; ET, embryo transfer; MⅡ, metaphase Ⅱ. 2PN, two pronuclei; 3PN, three pronuclei; 2PN oocytes rate (%) = 2PN/total number of cumulus oocyte complexes. Clinical pregnancy rate = No. of clinical pregnancy/fresh ET cycles.

3.3 Multivariate Logistic Regression Analysis was Performed

We stratified the number of oocytes obtained and conducted a regression analysis to further evaluate the association between co-incubation time and 2PN. Multivariate logistic regression analysis was performed with the 2PN rate as the dependent variable (<0.75 group and 0.75 group) and co-incubation time as the main independent variable. The analysis demonstrated that co-incubation time did not affect normal insemination after stratifying by the number of oocytes obtained while controlling for factors including sterility type, female age, AMH levels, average MⅡ oocytes, and stimulation protocol (p > 0.05, Table 3).

Table 3. Association between co-incubation time and 2PN rate.
Oocytes retrieved Gamete co-incubation time Adjusted OR (95% CI) p-value
1–10 S group Ref
L group 1.263 (0.922–1.729) 0.146
11–20 S group Ref
L group 1.340 (0.937–1.917) 0.109
>20 S group Ref
L group 0.925 (0.301–2.845) 0.892

AMH, anti-Müllerian hormone; Ref, reference group; OR, odds ratio; CI, confidence interval. Multivariate logistic regression analysis for association between 2PN and co-incubation time controlling for sterility type, female age, AMH, average MⅡ oocytes, and simulation protocol.

3.4 Basic Characteristics and Embryo Developmental Parameters of Partial Short Co-incubation

In the partial short co-incubation cycles, the gametes were split into the short part (10 oocytes) and the long part (the remaining oocytes) for co-incubation (Table 4). We analyzed embryo developmental parameters in the 2 parts. The rates of MⅡ oocytes, 2PN oocytes, 3PN oocytes, top-quality blastocysts on Day 5, and top-quality blastocysts on Day 6 were comparable between the 2 parts (Table 5).

Table 4. Patient characteristics of 79 partial short co-incubation.
Parameter Value
No. of cycles (n) 79
Female age, mean ± SD 29.59 ± 3.07
Duration of infertility (years) 3 [2, 5]
Primary infertility (%) 15/79 (18.99%)
Average oocytes retrieved (n) 23 [20, 27]
BMI (kg/m2) 22.60 [20.50, 27.40]
Female hormone levels
AMH (mg/dL) 5.80 [3.97, 8.79]
Baseline FSH (IU/L) 5.38 ± 1.39
Baseline LH (IU/L) 5.73 [4.41, 9.29]
Baseline E2 (ng/L) 38.03 [29.63, 49.71]
Simulation protocol
GnRH agonist (%) 31/79 (39.24%)
GnRH antagonist (%) 46/79 (58.23%)
Diagnoses
Tubal factor, n (%) 27/79 (34.18%)
Ovulatory obstacle, n (%) 23/79 (29.11%)
Unexplainable factor, (%) 13/79 (16.46%)

AMH, anti-Müllerian hormone; BMI, body mass index; FSH, follicle stimulating hormone; LH, luteinizing hormone; E2, basal estrogen; GnRH, gonadotropin releasing hormone; SD, standard deviation. Data are presented as the median [the first quartile, the third quartile] or count (percentage).

Table 5. Cycle characteristics and embryo developmental parameters of partial short co-incubation.
Short co-incubation Long co-incubation p-value
No. of oocytes (n) 790 1102
MII oocytes rate (%) 712/790 (90.13%) 962/1102 (87.30%) 0.060a
2PN oocytes rate (%) 570/712 (80.06%) 761/962 (79.11%) 0.634a
3PN oocytes rate (%) 73/712 (10.26%) 98/962 (10.19%) 0.965a
Top-quality cleavage embryo rate (%) 446/570 (78.25%) 607/761 (79.76%) 0.500a
Top-quality blastocyst embryo rate-Day 5 (%) 207/533 (38.84%) 305/741 (41.16%) 0.404a
Top-quality blastocyst embryo rate-Day 6 (%) 78/533 (14.63%) 97/741 (13.09%) 0.430a

Data are presented as count (percentage). MⅡ, metaphase Ⅱ; a, Chi-squared test.

4. Discussion

Conventional IVF is a widely used treatment for female infertility factors, unexplained infertility, and some male infertility factors. Total fertilization failure (TFF) remains challenging for clinicians and embryologists [17]. Short-term fertilization is a preferable method to avoid TFF, leading to the widespread use of short co-incubation of gametes combined with early rescue ICSI. It has been suggested that early removal of granulosa cells is beneficial for embryo quality [18], but some studies have shown conflicting results [10, 11]. Our study found a trend toward a higher polyspermy rate in the S group (8.71%) compared to the L group (7.96%), although this difference was not statistically significant. The top cleavage embryo rate was significantly higher in the S group, which can be attributed to the younger mean age and better ovarian function compared to the L group. In partial short fertilization, there was no discernible difference in the top cleavage embryo rate between the two groups. The rates of top-quality blastocyst, clinical pregnancy and implantation rates showed no significant differences between the two groups (p > 0.05). These findings are similar to other reports [11, 19].

Gianaroli et al. [12] indicated that sperm enter cumulus cells within 15 minutes, interact with them within 1 hour, and reach the oocyte cortex 4 hours later. These findings suggest that prolonged co-incubation of oocytes and sperm may not be necessary. Additionally, some researchers have found that prolonged co-incubation time may lead to high levels of reactive oxygen species (ROS) [5], which can negatively affect gamete interactions and embryo quality. However, Kong et al. [20] suggested that removing the cumulus-oocyte complex (COC) too early may interfere with the crucial communication between oocytes and the COC. While short co-incubation can decrease ROS levels, it may not provide sufficient time for oocyte maturation compared to longer incubation [20, 21]. We found that the normal fertilization rate (2PN) was slightly lower in the S group compared to the L group, with statistical significance (p < 0.01). Additionally, a self-matched control analysis of 79 partial short-duration patients showed no difference in 2PN rates between embryos in the short and long gamete co-incubation segments (p > 0.05). The analysis results are inconsistent. The populations of S Group and L Group are different, which affects inferences when analyzing the results of these 2 populations. The number of oocytes retrieved is considered a key factor in ovarian responsiveness to exogenous gonadotropin, and the number of oocytes retrieved for IVF treatment is related to clinical outcomes [17, 19]. According to the 2017 Vienna Consensus and the “Expert Consensus on Quality Control of Key Indicators of the Embryo Laboratory” the ideal normal fertilization rate of 2PN is 75% [22]. We stratified the number of oocytes obtained and conducted a regression analysis to further evaluate the association between co-incubation time and 2PN. The analysis demonstrated that co-incubation time did not affect normal insemination rate after stratifying by the number of oocytes obtained controlling for factors such as sterility type, female age, AMH levels, MⅡ oocytes, and stimulation protocol.

There are some limitations to our study. Due to the nature of retrospective study, it is possible that important confounder was not taken into account in the present study. It is a single-center study with a relatively small sample size. Cycles with three or fewer eggs, overnight fertilization was used to avoid, and fresh embryo transfer is not performed in these cycles in our center, which may potentially introduce bias. The live birth rates were not included in the results. Our plan is to accumulate more cases to further verify the conclusions.

Short-term insemination does not affect the fertilization rate and embryo development [3]. Furthermore, short co-incubation may require embryologists to work at night, resulting in longer working hours. Therefore, it is unnecessary to choose short fertilization in all IVF cycles. Clinicians should identify patients at risk for low or complete fertilization failure, and the fertilization method should be based on the history of infertility, the experience of clinicians and embryology laboratory personnel, and the patient’s medical history. The inclusion of additional procedures during fertilization evaluation may pose a potential risk of adverse effects on the fertilized egg [23]. Therefore, the method of selecting only some fertilized eggs, rather than all fertilized eggs for polar body observation helps to reduce the risk. Partial short insemination may be an appropriate method to reduce IVF fertilization failure or low fertilization rates.

5. Conclusions

Short and long oocyte-sperm co-incubation times have similar in vitro developmental outcomes. It is safe to use short-term fertilization for patients who may be at risk of fertilization failure.

Availability of Data and Materials

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Author Contributions

FC: investigation; formal analysis; writing—original draft; data curation. LL: investigation; formal analysis; writing—original draft. XD: formal analysis; writing—original draft. XX: formal analysis; writing—original draft. LC: conceptualization; methodology; writing—review and editing; funding acquisition. YW: conceptualization; methodology; writing—review and editing; funding acquisition; project administration. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of Changzhou Maternal and Child Health Care Hospital (approval number: 2022071).

Acknowledgment

We gratefully acknowledge the assistance and instruction from Dr. Zhu of the Department of Reproductive Medicine Center.

Funding

This research was funded by the China Reproductive Public Welfare Fund “Pilotage Plan” (grant SZ202412) and the Key Project of Changzhou Clinical Medical Center (grant CMCM202203).

Conflict of Interest

The authors declare no conflict of interest.

References

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.